Megan MacDonagh

Megan MacDonagh is currently a Vice President at SV Health Investors, where she focuses on venture capital investments within the healthcare and life sciences sectors. In her capacity at the firm, she is responsible for identifying, evaluating, and structuring equity deals with emerging companies that develop medical technologies and therapeutic solutions. Her role involves conducting rigorous due diligence on prospective healthcare investments and monitoring the strategic progress of existing portfolio companies. MacDonagh recently participated as a featured speaker at the Innovation Summit Dublin 2024, an industry conference centered on global healthcare developments and institutional investment trends. Through her ongoing work in the venture capital ecosystem, she facilitates the capitalization of early-stage life sciences enterprises. MacDonagh maintains a primary focus on deploying capital into specialized healthcare markets to generate institutional financial returns alongside clinical utility.